These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34575530)

  • 1. Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives.
    Xiroudaki S; Schoubben A; Giovagnoli S; Rekkas DM
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry powder inhalers (DPIs)--a review of device reliability and innovation.
    Islam N; Gladki E
    Int J Pharm; 2008 Aug; 360(1-2):1-11. PubMed ID: 18583072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
    Muralidharan P; Hayes D; Mansour HM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry powder inhalation: past, present and future.
    de Boer AH; Hagedoorn P; Hoppentocht M; Buttini F; Grasmeijer F; Frijlink HW
    Expert Opin Drug Deliv; 2017 Apr; 14(4):499-512. PubMed ID: 27534768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers.
    ElKasabgy NA; Adel IM; Elmeligy MF
    AAPS PharmSciTech; 2020 Aug; 21(7):238. PubMed ID: 32827062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements.
    Magramane S; Vlahović K; Gordon P; Kállai-Szabó N; Zelkó R; Antal I; Farkas D
    Pharmaceuticals (Basel); 2023 Nov; 16(12):. PubMed ID: 38139785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
    Sommerfeld M; Cui Y; Schmalfuß S
    Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.
    Islam N; Suwandecha T; Srichana T
    Daru; 2024 Dec; 32(2):761-779. PubMed ID: 38861247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro and particle image velocimetry studies of dry powder inhalers.
    Dos Reis LG; Chaugule V; Fletcher DF; Young PM; Traini D; Soria J
    Int J Pharm; 2021 Jan; 592():119966. PubMed ID: 33161040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation techniques for high dose dry powders.
    Brunaugh AD; Smyth HDC
    Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel pulmonary delivery system--dry powder inhalers].
    Tang Y; Zhu JB; Chen XJ
    Yao Xue Xue Bao; 2009 Jun; 44(6):571-4. PubMed ID: 19806884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler.
    Sorino C; Negri S; Spanevello A; Visca D; Scichilone N
    Eur J Intern Med; 2020 May; 75():15-18. PubMed ID: 32113944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties.
    Ambrus R; Benke E; Farkas Á; Balásházy I; Szabó-Révész P
    Eur J Pharm Sci; 2018 Oct; 123():20-27. PubMed ID: 30016647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder inhalers: an overview.
    Atkins PJ
    Respir Care; 2005 Oct; 50(10):1304-12; discussion 1312. PubMed ID: 16185366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder inhalers and the right things to remember: a concept review.
    Dal Negro RW
    Multidiscip Respir Med; 2015; 10(1):13. PubMed ID: 25878791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' usability of seven most used dry-powder inhalers in COPD.
    Dal Negro RW; Turco P; Povero M
    Multidiscip Respir Med; 2019; 14():30. PubMed ID: 31528340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.